MedTrace Logo

Efficacy of L-menthol on Breathlessness in Asthma

NCT07500974 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-03-30

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Asthma.

Conditions

Interventions

DRUG

L-menthol

(Sigma-Aldrich, St. Louis, US)

OTHER

Placebo

Strawberry scent (Sigma-Aldrich, St. Louis, US)

Sponsors & Collaborators

  • Blekinge Institute of Technology

    collaborator OTHER

  • Blekingesjukhuset, Karlskrona

    collaborator UNKNOWN

  • Region Skane

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2027-04-30
Completion
2027-05-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07500974 on ClinicalTrials.gov